COVID-19 excess mortality measured by the Global Health Security Index

Ven­tyx Bio­sciences has axed the de­vel­op­ment of its ex­per­i­men­tal pso­ri­a­sis drug af­ter lack­lus­ter Phase II re­sults, send­ing its stock plum­met­ing about 73% to $3.75 in

Eva Yin, the chief com­mer­cial of­fi­cer for Greater Chi­na at BeiGene, is re­port­ed­ly un­der in­ves­ti­ga­tion by lo­cal au­thor­i­ties for al­leged ties to an in­sur­ance fraud

In the wake of a tumultuous year, U.S. News & World Report announced that its annual “Best Medical Schools” rankings are set to be released